• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-8的受体识别和特异性由聚集在一个表面可及疏水口袋附近的残基决定。

Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.

作者信息

Hammond M E, Shyamala V, Siani M A, Gallegos C A, Feucht P H, Abbott J, Lapointe G R, Moghadam M, Khoja H, Zakel J, Tekamp-Olson P

机构信息

Chiron Corporation, Emeryville, California 94608, USA.

出版信息

J Biol Chem. 1996 Apr 5;271(14):8228-35. doi: 10.1074/jbc.271.14.8228.

DOI:10.1074/jbc.271.14.8228
PMID:8626516
Abstract

To determine the regions of interleukin-8 (IL-8) that allow high affinity and interleukin-8 receptor type 1 (IL8R1)-specific binding of chemokines, we produced chimeric proteins containing structural domains from IL-8, which binds to both IL8R1 and interleukin-8 receptor type 2 (IL8R2) with high affinity, and from GRO gamma, which does not bind to IL8R1 and binds to IL8R2 with reduced affinity. Receptor binding activity was tested by competition of 125I-IL-8 binding to recombinant IL8R1 and IL8R2 cell lines. Substitution into IL-8 of the GRO gamma sequences corresponding to either the amino-terminal loop (amino acids 1-18) or the first beta-sheet (amino acids 18-32) reduced binding to both IL8R1 and IL8R2. The third beta-sheet of IL-8 (amino acids 46-53) was required for binding to IL8R1 but not IL8R2. Exchanges of the second beta-sheet (amino acids 32-46) or the carboxyl-terminal alpha-helix (amino acids 53-72) had no significant effect. When IL-8 sequences were substituted into GRO gamma, a single domain containing the second beta-sheet of IL-8 (amino acids 18-32) was sufficient to confer high affinity binding for both IL8R1 and IL8R2. The amino-terminal loop (amino acids 1-18) and the third beta-sheet (amino acids 46-53) of IL-8 had little effect when substituted individually but showed increased binding to both receptors when substituted in combination. Individual amino acid substitutions were made at positions where IL-8 and GRO gamma sequences differ within the regions of residues 11-21 and 46-53. IL-8 mutations L49A or L49F selectively inhibited binding to IL8R1. Mutations Y13L and F21N enhanced binding to IL8R1 with little effect on IL8R2. A combined mutation Y13L/S14Q selectively decreased binding to IL8R2. Residues Tyr13, Ser14, Phe21, and Lys49 are clustered in and around a surface-accessible hydrophobic pocket on IL-8 that is physically distant from the previously identified ELR binding sequence. A homology model of GRO gamma, constructed from the known structure of IL-8 by refinement calculations, indicated that access to the hydrophobic pocket was effectively abolished in GRO gamma. These studies suggest that the surface hydrophobic pocket and/or adjacent residues participate in IL-8 receptor recognition for both IL8R1 and IL8R2 and that the hydrophobic pocket itself may be essential for IL8R1 binding. Thus this region contains a second site for IL-8 receptor recognition that, in combination with the Glu4-Leu5-Arg6 region, can modulate receptor binding affinity and IL8R1 specificity.

摘要

为了确定白细胞介素-8(IL-8)中允许趋化因子与白细胞介素-8受体1型(IL8R1)进行高亲和力且特异性结合的区域,我们制备了嵌合蛋白,其包含来自IL-8的结构域(IL-8能与IL8R1和白细胞介素-8受体2型(IL8R2)均以高亲和力结合)以及来自GROγ的结构域(GROγ不与IL8R1结合,与IL8R2的结合亲和力较低)。通过125I-IL-8与重组IL8R1和IL8R2细胞系结合的竞争试验来检测受体结合活性。将与氨基末端环(氨基酸1 - 18)或第一个β折叠(氨基酸18 - 32)相对应的GROγ序列替换到IL-8中,会降低其与IL8R1和IL8R2的结合。IL-8的第三个β折叠(氨基酸46 - 53)是与IL8R1结合所必需的,但与IL8R2结合不需要。第二个β折叠(氨基酸32 - 46)或羧基末端α螺旋(氨基酸53 - 72)的交换没有显著影响。当将IL-8序列替换到GROγ中时,一个包含IL-8第二个β折叠(氨基酸18 - 32)的单一结构域足以赋予其与IL8R1和IL8R2的高亲和力结合。IL-8的氨基末端环(氨基酸1 - 18)和第三个β折叠(氨基酸46 - 53)单独替换时影响较小,但组合替换时会增加与两种受体的结合。在氨基酸11 - 21和46 - 53区域内,对IL-8和GROγ序列不同的位置进行了单个氨基酸替换。IL-8突变L49A或L49F选择性抑制与IL8R1的结合。突变Y13L和F21N增强了与IL8R1的结合,对IL8R2影响较小。组合突变Y13L/S14Q选择性降低与IL8R2的结合。酪氨酸13、丝氨酸14、苯丙氨酸21和赖氨酸49聚集在IL-8表面可及的疏水口袋及其周围,该口袋在空间上远离先前确定的ELR结合序列。通过精细计算从IL-8的已知结构构建的GROγ同源模型表明,GROγ中该疏水口袋的可及性被有效消除。这些研究表明,表面疏水口袋和/或相邻残基参与了IL-8对IL8R1和IL8R2的受体识别,并且疏水口袋本身可能是与IL8R1结合所必需的。因此,该区域包含IL-8受体识别的第二个位点,与Glu4 - Leu5 - Arg6区域结合可调节受体结合亲和力和IL8R1特异性。

相似文献

1
Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.白细胞介素-8的受体识别和特异性由聚集在一个表面可及疏水口袋附近的残基决定。
J Biol Chem. 1996 Apr 5;271(14):8228-35. doi: 10.1074/jbc.271.14.8228.
2
Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO alpha and NAP-2.两种白细胞介素-8受体均可独立介导趋化作用。转染了IL-8R1或IL-8R2的Jurkat细胞会对IL-8、GROα和NAP-2产生迁移反应。
FEBS Lett. 1994 Mar 21;341(2-3):187-92. doi: 10.1016/0014-5793(94)80454-0.
3
CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.CXC趋化因子与独特的选择性决定簇集合相结合,这些决定簇能够独立发挥作用,并广泛分布于人类白细胞介素-8受体B的多个结构域上。高亲和力结合的决定簇和受体激活的决定簇是不同的。
J Biol Chem. 1996 Jan 5;271(1):225-32. doi: 10.1074/jbc.271.1.225.
4
Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities.交换白细胞介素-8与黑色素瘤生长刺激活性受体的结合特异性。
J Biol Chem. 1996 Jun 14;271(24):14344-52. doi: 10.1074/jbc.271.24.14344.
5
The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A.白细胞介素-8的酪氨酸13和赖氨酸15在与A型白细胞介素-8受体的高亲和力相互作用中的作用。
J Biol Chem. 1995 May 5;270(18):10428-31. doi: 10.1074/jbc.270.18.10428.
6
Structure and activity of a chimeric interleukin-8-melanoma-growth-stimulatory-activity protein.一种嵌合白细胞介素-8-黑色素瘤生长刺激活性蛋白的结构与活性
Eur J Biochem. 1996 Jan 15;235(1-2):26-35. doi: 10.1111/j.1432-1033.1996.00026.x.
7
The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes.白细胞介素8相关趋化细胞因子α、β和γ可激活人类嗜中性粒细胞和嗜碱性粒细胞。
J Biol Chem. 1993 Jul 25;268(21):15419-24.
8
The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.CXC趋化因子生长调节致癌基因(GRO)α、GROβ、GROγ、中性粒细胞激活肽-2和上皮细胞衍生的中性粒细胞激活肽-78是B型而非A型人白细胞介素8受体的有效激动剂。
J Biol Chem. 1996 Aug 23;271(34):20545-50. doi: 10.1074/jbc.271.34.20545.
9
Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.白细胞介素-8上负责与α和β白细胞介素-8受体结合的多个位点。
J Immunol. 1993 Dec 1;151(11):6418-28.
10
Discrete steps in binding and signaling of interleukin-8 with its receptor.白细胞介素-8与其受体结合及信号传导的离散步骤。
J Biol Chem. 1996 Dec 6;271(49):31202-9. doi: 10.1074/jbc.271.49.31202.

引用本文的文献

1
Conformational plasticity and dynamic interactions of the N-terminal domain of the chemokine receptor CXCR1.趋化因子受体 CXCR1 的 N 端结构域的构象可塑性和动态相互作用。
PLoS Comput Biol. 2021 May 20;17(5):e1008593. doi: 10.1371/journal.pcbi.1008593. eCollection 2021 May.
2
Porcine CXCR1/2 antagonist CXCL8G31P inhibits lung inflammation in LPS-challenged mice.猪趋化因子受体 1/2 拮抗剂 CXCL8G31P 抑制 LPS 刺激的小鼠肺部炎症。
Sci Rep. 2020 Jan 27;10(1):1210. doi: 10.1038/s41598-020-57737-w.
3
How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways.
趋化因子如何引导中性粒细胞到达靶位:解析结构机制和信号通路。
Cell Signal. 2019 Feb;54:69-80. doi: 10.1016/j.cellsig.2018.11.004. Epub 2018 Nov 19.
4
Structure of monomeric Interleukin-8 and its interactions with the N-terminal Binding Site-I of CXCR1 by solution NMR spectroscopy.通过溶液核磁共振光谱法研究单体白细胞介素-8的结构及其与CXCR1的N端结合位点-I的相互作用。
J Biomol NMR. 2017 Nov;69(3):111-121. doi: 10.1007/s10858-017-0128-3. Epub 2017 Nov 15.
5
Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration.趋化因子功能的调控:糖胺聚糖结合与翻译后硝化作用的角色
Int J Mol Sci. 2017 Aug 3;18(8):1692. doi: 10.3390/ijms18081692.
6
Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8K11R/G31P.K11R和G31P突变对CXCL8结构及生物学活性的影响:人CXCL8K11R/G31P的溶液结构
Molecules. 2017 Jul 21;22(7):1229. doi: 10.3390/molecules22071229.
7
A CXCL8 receptor antagonist based on the structure of N-acetyl-proline-glycine-proline.基于 N-乙酰脯氨酰-甘氨酰-脯氨酸结构的 CXCL8 受体拮抗剂。
Eur J Pharmacol. 2011 Oct 15;668(3):435-42. doi: 10.1016/j.ejphar.2011.02.045. Epub 2011 Mar 31.
8
Structural basis for differential binding of the interleukin-8 monomer and dimer to the CXCR1 N-domain: role of coupled interactions and dynamics.白细胞介素-8单体和二聚体与CXCR1 N结构域差异结合的结构基础:偶联相互作用和动力学的作用
Biochemistry. 2009 Sep 22;48(37):8795-805. doi: 10.1021/bi901194p.
9
Molecular requirements for sorting of the chemokine interleukin-8/CXCL8 to endothelial Weibel-Palade bodies.趋化因子白细胞介素-8/CXCL8分选至内皮细胞魏尔-帕拉德小体的分子要求
J Biol Chem. 2009 Aug 28;284(35):23532-9. doi: 10.1074/jbc.M900874200. Epub 2009 Jul 3.
10
Identification of GRO1 as a critical determinant for mutant p53 gain of function.鉴定GRO1是突变型p53功能获得的关键决定因素。
J Biol Chem. 2009 May 1;284(18):12178-87. doi: 10.1074/jbc.M900994200. Epub 2009 Mar 3.